Metabolix, Inc. (
Business Update Conference Call
January 12, 2012 5:00 pm ET
James Palczynski – ICR, Investor Relations
Richard P. Eno – President and Chief Executive Officer
Joseph D. Hill – Chief Financial Officer
Oliver P. Peoples – Co-Founder, Chief Scientific Officer
JinMing Liu – Ardour Capital Investments
Jeff Zekauskas – JPMorgan Securities, Inc.
Jeff Osborne – Stifel Nicolaus
Laurence Alexander – Jefferies & Co.
Good afternoon, ladies and gentlemen, welcome to the Metabolix Incorporated business update conference call. As a reminder, today’s call is being recorded.
I would now like to turn the conference over to Mr. James Palczynski of ICR. Please go ahead.
Thank you, operator, and good afternoon, everyone. Metabolix issued a press release after the market closed today. If you do not have a copy, one may be found on the website at www.metabolix.com in the Investor Relations section. Making the presentation today will be Richard Eno, President and Chief Executive Officer of Metabolix; and Joseph Hill, Chief Financial Officer of the Company. They are joined by Oliver Peoples, a Co-founder of Metabolix and Chief Scientific Officer.
Before we begin our formal remarks, I need to remind everyone that, part of our discussion today will include forward-looking statements. These statements are not guarantees of future performance, and therefore, undue reliance should not be put upon them. The Company undertakes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this conference call.